admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Awakn Life Sciences Acquires Exclusive Rights to MDMA Research from Imperial...

Numinus Completes Acquisition of Neurology Centre of Toronto

MindMed and Liechti Lab Provide Results from their Psilocybin R&D Collaboration

ATMA Journey Centers Offer Regulated Health Care Professionals a Means to...

MINDCURE Signs Exclusive Digital Clinical Data Licensing Agreement with ATMA Journey...

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Meet Microdosing TikTok—And Why the Community Matters

Tryp Therapeutics Submits IND Application for Phase 2a Clinical Trial in...

Bright Minds Biosciences Provides Scientific Update

Psychedelics: Past, Present, Future – Webinar

1...194195196...218 Page 195 of 218

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin